Importer of Controlled Substances Application: Cambridge Isotope Laboratories, 19083-19084 [2017-08346]

Download as PDF 19083 Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and of §§ 201.10 and 210.8(c) of the Commission’s Rules of Practice and Procedure (19 CFR 201.10, 210.8(c)). By order of the Commission. Dated: April 18, 2017. Lisa R. Barton, Secretary to the Commission. [FR Doc. 2017–08232 Filed 4–24–17; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on December 16, 2016, Janssen Ortho LLC, State Road 933 DM 0.1 Mamey Ward, Gurabo, Puerto Rico 00778 applied to be registered as an importer of tapentadol (9780), a basic class of controlled substance listed in schedule II. The company plans to import an intermediate form of tapentadol (9780) to bulk manufacture tapentadol for distribution to its customers. [Docket No. DEA–392] Dated: April 18, 2017. Louis J. Milione, Assistant Administrator. Importer of Controlled Substances Application: Janssen Ortho LLC [FR Doc. 2017–08345 Filed 4–24–17; 8:45 am] ACTION: Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before May 25, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before May 25, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been DATES: asabaliauskas on DSK3SPTVN1PROD with NOTICES BILLING CODE 4410–09–P Notice of application. VerDate Sep<11>2014 17:42 Apr 24, 2017 Jkt 241001 DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before June 26, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. DATES: PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 In accordance with 21 CFR 1301.33(a), this is notice that on June 1, 2016, Cedarburg Pharmaceuticals Inc., A Division of Albany Molecular Research Inc. (AMRI), 870 Badger Circle, Grafton, Wisconsin 53024 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled Substance Marihuana ................... Tetrahydrocannabinols Lisdexamfetamine ...... 4-Anilino-N-phenethyl4-piperidine (ANPP). Remifentanil ................ Fentanyl ...................... Drug Code Schedule 7360 7370 1205 8333 I I II II 9739 9801 II II The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers. In reference to drug codes 7360 marihuana, the company plans to bulk manufacture cannabidiol as a synthetic intermediate. This controlled substance will be further synthesized to bulk manufacture a synthetic tetrahydrocannabinols 7370. No other activity for this drug code is authorized for this registration. Dated: April 18, 2017. Louis J. Milione, Assistant Administrator. [FR Doc. 2017–08343 Filed 4–24–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: Cambridge Isotope Laboratories ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before May 25, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before May 25, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement DATES: E:\FR\FM\25APN1.SGM 25APN1 19084 Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers importers, and exporters of, controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on August 25, 2016, Cambridge Isotope Laboratories, 50 Frontage Road, Andover, Massachusetts 01810 applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance Drug code Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................. Gamma Hydroxybutyric Acid ......................................................................................................................................... Methaqualone ................................................................................................................................................................ Lysergic acid diethylamide ............................................................................................................................................ Marihuana ...................................................................................................................................................................... Tetrahydrocannabinols .................................................................................................................................................. 3,4-Methylenedioxyamphetamine .................................................................................................................................. 3,4-Methylenedioxy-N-ethylamphetamine ..................................................................................................................... 3,4-Methylenedioxymethamphetamine .......................................................................................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) .................................................................................................... Butylone ......................................................................................................................................................................... Heroin ............................................................................................................................................................................ Pentobarbital .................................................................................................................................................................. Secobarbital ................................................................................................................................................................... Phencyclidine ................................................................................................................................................................. Cocaine .......................................................................................................................................................................... Dihydrocodeine .............................................................................................................................................................. Ecgonine ........................................................................................................................................................................ Meperidine ..................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) ............................................................................................................ Fentanyl ......................................................................................................................................................................... The company plans to import the listed controlled substances for analytical research, testing and clinical trials. Dated: April 18, 2017. Louis J. Milione, Assistant Administrator. [FR Doc. 2017–08346 Filed 4–24–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC asabaliauskas on DSK3SPTVN1PROD with NOTICES ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before June 26, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and SUPPLEMENTARY INFORMATION: Drug code Gamma Hydroxybutyric Acid ......................................................................................................................................... Dihydromorphine ............................................................................................................................................................ Hydromorphinol .............................................................................................................................................................. Methylphenidate ............................................................................................................................................................. Amobarbital .................................................................................................................................................................... Pentobarbital .................................................................................................................................................................. Secobarbital ................................................................................................................................................................... 17:42 Apr 24, 2017 Jkt 241001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 I I I I I I I I I I I I II II II II II II II II II implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on November 22, 2016, Siegfried USA, LLC, 33 Industrial Park Road, Pennsville, New Jersey 08070 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance VerDate Sep<11>2014 1248 2010 2565 7315 7360 7370 7400 7404 7405 7540 7541 9200 2270 2315 7471 9041 9120 9180 9230 9273 9801 Schedule E:\FR\FM\25APN1.SGM 25APN1 2010 9145 9301 1724 2125 2270 2315 Schedule I I I II II II II

Agencies

[Federal Register Volume 82, Number 78 (Tuesday, April 25, 2017)]
[Notices]
[Pages 19083-19084]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08346]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Cambridge Isotope 
Laboratories

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.34(a) on or before May 25, 2017. Such persons may also file a 
written request for a hearing on the application pursuant to 21 CFR 
1301.43 on or before May 25, 2017.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement

[[Page 19084]]

Administration, Attn: Administrator, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for hearing should also be 
sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 
8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug 
Enforcement Administration, Attn: DEA Federal Register Representative/
DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers importers, and exporters of, 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on August 
25, 2016, Cambridge Isotope Laboratories, 50 Frontage Road, Andover, 
Massachusetts 01810 applied to be registered as an importer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
        Controlled substance             Drug code         Schedule
------------------------------------------------------------------------
Mephedrone (4-Methyl-N-                         1248  I
 methylcathinone).
Gamma Hydroxybutyric Acid...........            2010  I
Methaqualone........................            2565  I
Lysergic acid diethylamide..........            7315  I
Marihuana...........................            7360  I
Tetrahydrocannabinols...............            7370  I
3,4-Methylenedioxyamphetamine.......            7400  I
3,4-Methylenedioxy-N-                           7404  I
 ethylamphetamine.
3,4-Methylenedioxymethamphetamine...            7405  I
Methylone (3,4-Methylenedioxy-N-                7540  I
 methylcathinone).
Butylone............................            7541  I
Heroin..............................            9200  I
Pentobarbital.......................            2270  II
Secobarbital........................            2315  II
Phencyclidine.......................            7471  II
Cocaine.............................            9041  II
Dihydrocodeine......................            9120  II
Ecgonine............................            9180  II
Meperidine..........................            9230  II
Dextropropoxyphene, bulk (non-dosage            9273  II
 forms).
Fentanyl............................            9801  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
analytical research, testing and clinical trials.

    Dated: April 18, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-08346 Filed 4-24-17; 8:45 am]
 BILLING CODE 4410-09-P